Difference between revisions of "About-cancer/treatment/drugs/skin"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Skin Cancer == | + | == Drugs Approved for Skin Cancer == <!--T:1--> |
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here. | ||
| + | <!--T:3--> | ||
'''ON THIS PAGE''' | '''ON THIS PAGE''' | ||
| + | <!--T:4--> | ||
*Drugs Approved for Basal Cell Carcinoma | *Drugs Approved for Basal Cell Carcinoma | ||
| + | <!--T:5--> | ||
*Drugs Approved for Cutaneous Squamous Cell Carcinoma | *Drugs Approved for Cutaneous Squamous Cell Carcinoma | ||
| + | <!--T:6--> | ||
*Drugs Approved for Melanoma | *Drugs Approved for Melanoma | ||
| + | <!--T:7--> | ||
*Drugs Approved for Merkel Cell Carcinoma | *Drugs Approved for Merkel Cell Carcinoma | ||
| + | <!--T:8--> | ||
'''Drugs Approved for Basal Cell Carcinoma''' | '''Drugs Approved for Basal Cell Carcinoma''' | ||
| + | <!--T:9--> | ||
Aldara (Imiquimod) | Aldara (Imiquimod) | ||
| + | <!--T:10--> | ||
Efudex (Fluorouracil--Topical) | Efudex (Fluorouracil--Topical) | ||
| + | <!--T:11--> | ||
Erivedge (Vismodegib) | Erivedge (Vismodegib) | ||
| + | <!--T:12--> | ||
5-FU (Fluorouracil--Topical) | 5-FU (Fluorouracil--Topical) | ||
| + | <!--T:13--> | ||
Fluorouracil--Topical | Fluorouracil--Topical | ||
| + | <!--T:14--> | ||
Imiquimod | Imiquimod | ||
| + | <!--T:15--> | ||
Odomzo (Sonidegib) | Odomzo (Sonidegib) | ||
| + | <!--T:16--> | ||
Sonidegib | Sonidegib | ||
| + | <!--T:17--> | ||
Vismodegib | Vismodegib | ||
| + | <!--T:18--> | ||
'''Drugs Approved for Cutaneous Squamous Cell Carcinoma''' | '''Drugs Approved for Cutaneous Squamous Cell Carcinoma''' | ||
| + | <!--T:19--> | ||
Cemiplimab-rwlc | Cemiplimab-rwlc | ||
| + | <!--T:20--> | ||
Libtayo (Cemiplimab-rwlc) | Libtayo (Cemiplimab-rwlc) | ||
| + | <!--T:21--> | ||
'''Drugs Approved for Melanoma''' | '''Drugs Approved for Melanoma''' | ||
| + | <!--T:22--> | ||
Aldesleukin | Aldesleukin | ||
| + | <!--T:23--> | ||
Cobimetinib | Cobimetinib | ||
| + | <!--T:24--> | ||
Cotellic (Cobimetinib) | Cotellic (Cobimetinib) | ||
| + | <!--T:25--> | ||
Dabrafenib | Dabrafenib | ||
| + | <!--T:26--> | ||
Dacarbazine | Dacarbazine | ||
| + | <!--T:27--> | ||
DTIC-Dome (Dacarbazine) | DTIC-Dome (Dacarbazine) | ||
| + | <!--T:28--> | ||
IL-2 (Aldesleukin) | IL-2 (Aldesleukin) | ||
| + | <!--T:29--> | ||
Imlygic (Talimogene Laherparepvec) | Imlygic (Talimogene Laherparepvec) | ||
| + | <!--T:30--> | ||
Interleukin-2 (Aldesleukin) | Interleukin-2 (Aldesleukin) | ||
| + | <!--T:31--> | ||
Intron A (Recombinant Interferon Alfa-2b) | Intron A (Recombinant Interferon Alfa-2b) | ||
| + | <!--T:32--> | ||
Ipilimumab | Ipilimumab | ||
| + | <!--T:33--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:34--> | ||
Mekinist (Trametinib) | Mekinist (Trametinib) | ||
| + | <!--T:35--> | ||
Nivolumab | Nivolumab | ||
| + | <!--T:36--> | ||
Opdivo (Nivolumab) | Opdivo (Nivolumab) | ||
| + | <!--T:37--> | ||
Peginterferon Alfa-2b | Peginterferon Alfa-2b | ||
| + | <!--T:38--> | ||
Pembrolizumab | Pembrolizumab | ||
| + | <!--T:39--> | ||
Proleukin (Aldesleukin) | Proleukin (Aldesleukin) | ||
| + | <!--T:40--> | ||
Recombinant Interferon Alfa-2b | Recombinant Interferon Alfa-2b | ||
| + | <!--T:41--> | ||
Sylatron (Peginterferon Alfa-2b) | Sylatron (Peginterferon Alfa-2b) | ||
| + | <!--T:42--> | ||
Tafinlar (Dabrafenib) | Tafinlar (Dabrafenib) | ||
| + | <!--T:43--> | ||
Talimogene Laherparepvec | Talimogene Laherparepvec | ||
| + | <!--T:44--> | ||
Trametinib | Trametinib | ||
| + | <!--T:45--> | ||
Vemurafenib | Vemurafenib | ||
| + | <!--T:46--> | ||
Yervoy (Ipilimumab) | Yervoy (Ipilimumab) | ||
| + | <!--T:47--> | ||
Zelboraf (Vemurafenib) | Zelboraf (Vemurafenib) | ||
| + | <!--T:48--> | ||
'''Drugs Approved for Merkel Cell Carcinoma''' | '''Drugs Approved for Merkel Cell Carcinoma''' | ||
| + | <!--T:49--> | ||
Avelumab | Avelumab | ||
| + | <!--T:50--> | ||
Bavencio (Avelumab) | Bavencio (Avelumab) | ||
| + | <!--T:51--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:52--> | ||
Pembrolizumab | Pembrolizumab | ||
</translate> | </translate> | ||
Latest revision as of 21:39, 29 October 2019
Drugs Approved for Skin Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here.
ON THIS PAGE
- Drugs Approved for Basal Cell Carcinoma
- Drugs Approved for Cutaneous Squamous Cell Carcinoma
- Drugs Approved for Melanoma
- Drugs Approved for Merkel Cell Carcinoma
Drugs Approved for Basal Cell Carcinoma
Aldara (Imiquimod)
Efudex (Fluorouracil--Topical)
Erivedge (Vismodegib)
5-FU (Fluorouracil--Topical)
Fluorouracil--Topical
Imiquimod
Odomzo (Sonidegib)
Sonidegib
Vismodegib
Drugs Approved for Cutaneous Squamous Cell Carcinoma
Cemiplimab-rwlc
Libtayo (Cemiplimab-rwlc)
Drugs Approved for Melanoma
Aldesleukin
Cobimetinib
Cotellic (Cobimetinib)
Dabrafenib
Dacarbazine
DTIC-Dome (Dacarbazine)
IL-2 (Aldesleukin)
Imlygic (Talimogene Laherparepvec)
Interleukin-2 (Aldesleukin)
Intron A (Recombinant Interferon Alfa-2b)
Ipilimumab
Keytruda (Pembrolizumab)
Mekinist (Trametinib)
Nivolumab
Opdivo (Nivolumab)
Peginterferon Alfa-2b
Pembrolizumab
Proleukin (Aldesleukin)
Recombinant Interferon Alfa-2b
Sylatron (Peginterferon Alfa-2b)
Tafinlar (Dabrafenib)
Talimogene Laherparepvec
Trametinib
Vemurafenib
Yervoy (Ipilimumab)
Zelboraf (Vemurafenib)
Drugs Approved for Merkel Cell Carcinoma
Avelumab
Bavencio (Avelumab)
Keytruda (Pembrolizumab)
Pembrolizumab
